Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

ClinicalTrials.gov ID: NCT00395070

Public ClinicalTrials.gov record NCT00395070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 5:24 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment With 2 mg Intralesional Allovectin-7® Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects With Recurrent Metastatic Melanoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the safety and efficacy of Allovectin-7® versus Dacarbazine (DTIC)or Temozolomide (TMZ) in subjects with recurrent stage 3 or stage 4 melanoma.

Study identification

NCT ID
NCT00395070
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vical
Industry
Enrollment
390 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2006 (Type not available)
Primary completion
Mar 2012 (Actual)
Completion
Jul 2013 (Actual)
Last update posted
Sep 13, 2013

2006 – 2013

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Location #40 Tucson Arizona 85724 —
Location #9 Little Rock Arkansas 72205 —
Location #1 Bakersfield California 93309 —
Location #24 San Diego California 92093 —
Location #36 San Diego California 92161 —
Location #47 San Francisco California 94117 —
Location #16 Denver Colorado 80045 —
Location #11 Lakeland Florida 33805 —
Location #7 Chicago Illinois 60068 —
Location #33 Chicago Illinois 60612 —
Location #20 Louisville Kentucky 40202 —
Location #35 Baltimore Maryland 21202 —
Location #4 Kansas City Missouri 64111 —
Location #19 St Louis Missouri 63110 —
Location #38 Hackensack New Jersey 07601 —
Location #8 Montclair New Jersey 07042 —
Location #87 Albuquerque New Mexico 87131 —
Location #41 Cincinnati Ohio 45219 —
Location #23 Cleveland Ohio 44106 —
Location #34 Portland Oregon 97239 —
Location #12 Bethlehem Pennsylvania 18015 —
Location #97 Providence Rhode Island 02903 —
Location #28 Dallas Texas 75246 —
Location #117 Houston Texas 77030 —
Location #27 Salt Lake City Utah 84103 —
Location #26 Salt Lake City Utah 84112 —
Location #32 Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00395070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 13, 2013 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00395070 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →